Hives treatment developer Third Harmonic prices upsized $185M IPO (Pending:THRD)
Mikko Lemola Hives treatment developer Third Harmonic Bio (THRD) has priced its upsized $185M initial public offering. The biotech company ...
Mikko Lemola Hives treatment developer Third Harmonic Bio (THRD) has priced its upsized $185M initial public offering. The biotech company ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.